Taxes prove futile to burn out cigarette use in India

Now I have sufficient facts. Let me write the UPSC study note.

Taxes Prove Futile to Burn Out Cigarette Use in India

UPSC Prelims + Mains Study Note

1. At a Glance

• India is the world's second-largest consumer and producer of tobacco, making tobacco taxation a critical public health and fiscal policy issue. [S1]
• Cigarette taxes account for only 53% of the retail price — far below the WHO benchmark of 75% needed to significantly deter consumption, especially among youth and low-income users. [S2]
• Tobacco kills ~1.35 million Indians annually (≈3,600/day) from cancer, cardiovascular disease, lung disease, and stroke; the WHO estimates tobacco costs India ~1% of GDP in disease burden and early deaths. [S1][S3]
• The GST framework structurally weakened excise-based tobacco taxation post-2017, while beedis — India's most-consumed smoking product — attract a mere 22% tax burden. [S2]

2. Why in the News

• A February 2026 article (The Hindu Business Line, 18 Feb 2026) highlighted that India's cigarette tax share (53%) remains well below the WHO's 75% deterrence benchmark, with GST on beedis reduced to 18%, triggering renewed debate on tobacco tax reform. [S1][S5]
• The Central Excise (Amendment) Bill, 2025, introduced in Lok Sabha on 1 December 2025, proposed increases in excise duties on tobacco products. [S4]
• The GST Compensation Cess, applied to tobacco, was due to expire on 31 March 2026; policy debate has centred on replacing it with a dedicated Health Cess to maintain deterrence and revenue. [S2]
• New Pictorial Health Warning rules were notified by the Ministry of Health & Family Welfare on 3 December 2024, mandating warnings on 85% of the principal display area on both sides of tobacco packages. [S6]

3. Background & Evolution

• 1975: Cigarettes Act mandated health warnings on packs — India's first statutory tobacco control measure.
• 2003: COTPA (Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) Act, 2003) — the principal legislation governing tobacco in India. [S6]
• 2004: India ratified the WHO Framework Convention on Tobacco Control (WHO FCTC) — the first international treaty under WHO auspices. [S3]
• 2007–08: National Tobacco Control Programme (NTCP) launched under Ministry of Health & Family Welfare with objectives of awareness, supply reduction, COTPA enforcement, and Tobacco Cessation Centres (TCCs). [S6]
• 2017: Introduction of GST restructured tobacco taxation; excise duty share on cigarettes collapsed from 54% to ~8%; Compensation Cess partially compensated but left structural gaps. [S2]
• 2016–17: Global Adult Tobacco Survey (GATS-2) found 267 million adults (29%) use tobacco in India. [S6]
• 2019: PECA (Prohibition of Electronic Cigarettes Act, 2019) banned e-cigarettes, HTPs (heated tobacco products), and similar devices. [S6]
• 2024: Ministry of Health updated Law Enforcers' Guidelines for COTPA 2003 and PECA 2019. [S6]
• 2025: Central Excise (Amendment) Bill, 2025 introduced; debate over Health Cess post-Compensation Cess expiry. [S4]

4. Core Static Facts

5. Multi-Dimensional Analysis

Economic

• Tobacco is a major revenue source for the Union government through GST + Compensation Cess + NCCD (National Calamity Contingent Duty); its taxation is contested between revenue maximisation and health deterrence. [S2]
• WHO estimates India loses ~1% of GDP annually to tobacco-related healthcare costs and productivity losses — a figure that likely exceeds tobacco tax revenues. [S3]
• Post-GST, excise duty on cigarettes fell from 54% to ~8% of retail price, effectively reducing the deterrence component of the tax structure. [S2]
• The proposed Health Cess (post-Compensation Cess expiry) is modelled on MPOWER framework economics — earmarking tobacco revenue for health spending.

Social

• Beedis are disproportionately consumed by low-income and rural populations — yet attract only 22% tax burden vs. 53% for cigarettes, making the tax system regressive in health impact terms. [S2]
• Youth and low-income users are most price-sensitive; the WHO's 75% benchmark specifically targets deterrence in these groups. [S1]
• Smokeless tobacco (khaini, gutkha, zarda) is the dominant form (not cigarettes) — used by a majority of India's 267 million tobacco users; oral cancer is a major consequence. [S6]
• Tobacco industry influence on policy (Commercial Determinants of Health) is documented — all sectors of the industry have been shown to shape tobacco control policy in India. [S1]

Legal / Constitutional

• COTPA, 2003 prohibits tobacco advertising, mandates health warnings, bans sale to/near minors (<18 yrs, within 100m of educational institutions). [S6]
• PECA, 2019 provides for complete prohibition of e-cigarettes, HTPs; offences are cognisable and bailable. [S6]
• WHO FCTC Article 6 specifically requires Parties to implement tax and price measures to reduce tobacco demand — India's 53% tax rate is non-compliant with the spirit of this obligation. [S3]
• GST Council decisions on tobacco rates operate under Schedule IV of the CGST Act, with tobacco classified in the highest tax slab + cess.

Ethical / Governance

• The tobacco industry's documented interference in policy (via lobbying, litigation, and regulatory capture) is a governance challenge — the article cites all sectors influencing tobacco-control policy. [S1]
• Differential treatment of beedis (lower taxes despite equivalent health harm) reflects political economy pressures from the beedi industry workforce (~4.5 million workers), creating an ethical conflict between livelihoods and public health.
• Earmarking tobacco tax revenues for health (Health Cess model) raises accountability questions about whether proceeds actually fund tobacco cessation and cancer treatment infrastructure.

Administrative

• NTCP implementation is Centre-State concurrent; States enforce COTPA at the ground level via local health authorities and police.
• Tobacco Cessation Centres (TCCs) under NTCP are underfunded and geographically sparse relative to India's 267 million tobacco users. [S6]
• GST Council's unanimous consent requirement for cess/rate changes creates federal bottleneck in tobacco tax reform. [S2]

6. Recent Developments (Last 12–18 Months)

• December 2024: Ministry of Health & Family Welfare notified new Pictorial Health Warning rules — warnings to cover 85% of display area on both sides of tobacco packages. [S6]
• December 2024: Ministry updated Law Enforcers' Guidelines for COTPA 2003 and PECA 2019. [S6]
• 1 December 2025: Central Excise (Amendment) Bill, 2025 introduced in Lok Sabha, proposing enhanced excise duties on tobacco products. [S4]
• 31 March 2026: GST Compensation Cess expiry — policy debate ongoing on replacing with Health Cess dedicated to tobacco control and NCDs. [S2]
• February 2026: Renewed media/academic attention on India's sub-WHO-benchmark cigarette tax rate (53% vs. 75%), and beedi GST reduction to 18%. [S1]

7. Prelims Hooks

• India is the world's second-largest consumer and producer of tobacco (not first — China is first). [S1]
• WHO recommends tobacco taxes constitute at least 75% of the retail price to significantly deter consumption. [S2]
• India's cigarette taxes stand at 53% of retail price — below the WHO 75% benchmark. [S1][S2]
• Beedi tax burden is only 22% of retail price; beedis are exempt from the GST Compensation Cess. [S2]
• Post-GST 2017, excise duty share on cigarettes fell from 54% to ~8% of retail price. [S2]
• Principal tobacco control legislation: COTPA, 2003 (Cigarettes and Other Tobacco Products Act). [S6]
• India ratified WHO FCTC in 2004 — first global health treaty under WHO auspices. [S3]
• PECA, 2019 bans e-cigarettes and heated tobacco products (HTPs) in India. [S6]
• NTCP launched in 2007–08 under the Ministry of Health & Family Welfare. [S6]
• 267 million adults (29%) in India use tobacco — GATS-2, 2016–17. [S6]
• Tobacco kills approximately 1.35 million Indians per year (WHO estimate). [S1]
• India loses approximately 1% of GDP to tobacco-related disease and early death (WHO, 2021). [S3]
• New pictorial health warnings must cover 85% of the principal display area on both sides of packs — notified 3 December 2024. [S6]
• Bidi (9%) is more commonly smoked than cigarette (6%) among Indian adults per GATS-2. [S6]
• The Central Excise (Amendment) Bill, 2025 was introduced in Lok Sabha on 1 December 2025. [S4]

8. Mains Relevance

GS Paper mapping: - GS-II: Government policies and interventions for development in various sectors; health governance; issues relating to development and management of social sector services; role of NGOs and international bodies (WHO, FCTC). - GS-III: Taxation — GST, Compensation Cess, fiscal policy; inclusive growth; effects of liberalisation on the economy. - GS-IV: Ethics in governance — corporate/industry lobbying vs. public health; conflict between revenue and welfare objectives.

Plausible Mains Question Stems: 1. "India's tobacco tax structure, particularly after the introduction of GST, has undermined public health goals while failing to meet WHO benchmarks. Critically examine." 2. "Despite being a signatory to the WHO FCTC, India's tobacco control measures remain inadequate. Analyse the structural, political, and economic reasons for this gap." 3. "The differential tax treatment of beedis and cigarettes in India reflects a complex interplay of public health priorities, political economy, and livelihood concerns. Discuss."

9. Related Topics to Study Next

10. Common Errors / Trap Areas

1. India as the largest tobacco consumer — India is the second-largest (not first); China leads. Do not confuse rank.
2. Conflating COTPA and FCTC — COTPA (2003) is India's domestic law; FCTC (ratified 2004) is the international treaty. They are complementary but distinct instruments.
3. Beedi misconception — Aspirants often assume beedis attract higher or equal taxes to cigarettes due to health parity. In reality, beedis face a much lower burden (22%) and are exempt from Compensation Cess.
4. PECA 2019 scope — PECA bans e-cigarettes, HTPs, vapes — it does not amend COTPA. The two Acts cover different product categories; mixing them in answers is a common error.
5. GST rate vs. effective tax burden — The headline GST rate of 28% + cess on cigarettes does not equal the share of tax in retail price (53%); confusing these two figures leads to incorrect MCQ answers.

11. Sources

• [S1] "Taxes prove futile to burn out cigarette use in India" — The Hindu Business Line, 18 February 2026 — (Tier 4) (Article excerpt provided as primary source)
• [S2] "Rethinking taxes on tobacco and sugary drinks in India" — World Bank Blog — https://blogs.worldbank.org/en/endpovertyinsouthasia/rethinking-taxes-on-tobacco-and-sugary-drinks-in-india — (Tier 2)
• [S3] "India loses 1% of its GDP to diseases and early deaths from tobacco use, finds WHO study" — WHO India — https://www.who.int/india/news-room/detail/09-02-2021-india-loses-1-of-its-gdp-to-diseases-and-early-deaths-from-tobacco-use-finds-who-study — (Tier 2)
• [S4] "The Central Excise (Amendment) Bill, 2025" — PRS India — https://prsindia.org/billtrack/the-central-excise-amendment-bill-2025 — (Tier 1)
• [S5] "Tobacco Taxes in India — Highlights of Tax Affordability Study" — WHO SEARO — https://cdn.who.int/media/docs/default-source/searo/india/tobacoo/highlights-of-tax-affordability-study7jan-final.pdf — (Tier 2)
• [S6] "Consumption of Tobacco Products / National Tobacco Control Programme" — PIB, Ministry of Health & Family Welfare — https://www.pib.gov.in/newsite/PrintRelease.aspx?relid=98406 — (Tier 1)

Sources (inline): - Rethinking taxes on tobacco and sugary drinks in India - India loses 1% of its GDP to tobacco — WHO India - The Central Excise (Amendment) Bill, 2025 — PRS India - Tobacco Taxes in India — WHO SEARO - Consumption of Tobacco Products — PIB